SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-252361
Filing Date
2023-10-06
Accepted
2023-10-06 16:01:04
Documents
15
Period of Report
2023-10-06
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d534754d8k.htm   iXBRL 8-K 39590
2 EX-99.1 d534754dex991.htm EX-99.1 41030
7 GRAPHIC g534754sp001.jpg GRAPHIC 5206
  Complete submission text file 0001193125-23-252361.txt   255368

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20231006.xsd EX-101.SCH 3285
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20231006_def.xml EX-101.DEF 13058
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20231006_lab.xml EX-101.LAB 21662
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20231006_pre.xml EX-101.PRE 13765
9 EXTRACTED XBRL INSTANCE DOCUMENT d534754d8k_htm.xml XML 5294
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 231314204
SIC: 2836 Biological Products, (No Diagnostic Substances)